Advanced Search

 

Study ID Status Title Patient Level Data
205512 Recruiting Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero®) vaccination in routine UK care
205514 Recruiting Post-licensure observational effectiveness study of meningococcal B vaccine 4CMenB (Bexsero®) vaccination
205523 Completed Feasibility study for identifying a sero-correlate of protection against invasive Group B Streptococcus disease in newborns and young infants aged less ≤90 days
205531 Recruiting MENVEO® pregnancy registry: an observational study on the safety of MENVEO exposure in pregnant women and their offspring
205533 Recruiting 4CMenB pregnancy registry: an observational study of the safety of 4CMenB exposure in pregnant women and their offspring.
205534 Active, not recruiting Post-licensure observational safety surveillance study of quadrivalent meningococcal ACWY conjugate vaccine MenACWY-CRM (MENVEO®) in children 2 months through 23 months of age.
205540 Recruiting A randomised, double-blind, placebo-controlled, parallel group, 8-week treatment study to investigate the safety, pharmacodynamics, and effect of the TLR7 agonist, GSK2245035, on the allergen-induced asthmatic response in subjects with mild allergic asthma
205613 Recruiting A Phase 2b Open-Label Multi-Center Study Assessing the Immunological Persistence of Antibodies at Approximately 2 years After the last Meningococcal Vaccination in Study V102_15 (NCT02212457) and the Response to a Booster dose of GSK MenABCWY or Meningococcal Serogroup B Vaccines, in Healthy Adolescents
205633 Not yet recruiting Severe Asthma: Characterizing Patient Impacts of Frequent/Chronic Use of Oral Corticosteroids
205634 Completed A phase IV, open label, single-center extension study, to evaluate the long-term persistence of immune responses after post-exposure prophylaxis with purified chicken-embryo cell rabies Vaccine in Chinese children
205636 Completed A Randomized, Parallel-Group, Placebo-Controlled Study to Evaluate the Local Nasal Tolerability and Safety of 1146A in Healthy Adult Subjects
205637 Withdrawn An open-label, multicenter, randomized, parallel group, single-dose study to assess the short term efficacy and safety of paracetamol 500 mg + phenylephrine HCl 10 mg + pheniramine maleate 20 mg + vitamin C 200 mg powder for oral solution in subjects with symptoms of an upper respiratory tract infection
205638 Withdrawn An open-label, multicenter, randomized, parallel group, single-dose study to assess the short term efficacy and safety of paracetamol 500 mg + phenylephrine HCl 10 mg + vitamin C 200 mg powder for oral solution in subjects with symptoms of an upper respiratory tract infection
205639 Recruiting Meta-analysis of the risk of autoimmune thyroiditis diseases, Guillain-Barré Syndrome, and Inflammatory Bowel Disease with Cervarix Vaccination
205643 Completed PGx7654: Pharmacogenetic investigation of the association of the beta2-adrenergic receptor (ADRB2) Thr164Ile variant with risk of hospitalization due to asthma exacerbations
205653 Not yet recruiting Relvar 100 Ellipta Special Drug Use Investigation (COPD, Long-term)
205654 Not yet recruiting MALARONE Pediatric Combination Tablets Special Drug Use Investigation
205665 Recruiting A randomized, open-label study to evaluate the effect of daprodustat on blood pressure in subjects with anemia associated with chronic kidney disease on hemodialysis switched from a stable dose of an erythropoiesis-stimulating agent
205667 Active, not recruiting An open-label, single arm, repeat dose, multi-centre study to evaluate the use of a safety syringe for the subcutaneous administration of mepolizumab in subjects with severe eosinophilic asthma (Study 205667)
205670 Recruiting A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subjects
205684 Completed A Randomized, Parallel-Group, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Subjects with Symptoms of Common Cold
205687 Recruiting A randomised, double-blind, parallel group PhIII study to assess the clinical efficacy and safety of 100 mg SC Mepolizumab as an add on to maintenance treatment in adults with severe bilateral nasal polyps
205689 Terminated Effects of cold and/or flu on motivation, mood and cognitive performance in otherwise healthy individuals
205694 Completed An open-label, randomized, single-dose, two-period cross-over study to evaluate bioequivalence of GSK3542503 hydrochlorothiazide + amiloride hydrochloride 50 mg: 5 mg fixed dose combination tablets versus reference product in healthy adult participants under fasting conditions
205697 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.